Avidity Biosciences, Inc. - RNAM

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A RA Capital Management, L.P. 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A Peter Kolchinsky 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A Rajeev Shah 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A RA Capital Healthcare Fund, L.P. 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 4.6% 6,939,503 View
Feb 17, 2026 SCHEDULE 13G/A Avoro Capital Advisors LLC 5.54% 8,515,792 View
Feb 17, 2026 SCHEDULE 13G/A Behzad Aghazadeh 5.54% 8,515,792 View
Feb 17, 2026 SCHEDULE 13G/A T. Rowe Price Associates, Inc. 0.1% 142,888 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Management Group LLP 0.5% 723,118 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Group Holdings LLP 0.5% 723,118 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Investment Advisors Holdings LLP 0.5% 723,118 View
Dec 05, 2025 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 5.5% 8,224,930 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.